Table of Contents for U.S. Market for IV Therapy and Vein Access
|
INTRODUCTION |
XIII |
|
STUDY GOALS AND OBJECTIVES |
XIII |
|
REASONS FOR STUDY |
XIII |
|
SCOPE OF STUDY |
XIII |
|
METHODOLOGY AND INFORMATION SOURCES |
XIV |
|
ANALYST CREDENTIALS |
XIV |
|
RELATED BCC REPORTS |
XV |
|
BCC ONLINE SERVICES |
XV |
|
DISCLAIMER |
XVI |
|
EXECUTIVE SUMMARY |
XVII |
|
EXECUTIVE SUMMARY |
XVII |
|
Summary Table: |
XVIII |
|
Summary Figure: |
XIX |
|
INDUSTRY OVERVIEW |
1 |
|
HISTORICAL DEVELOPMENT OF TRANSFUSION THERAPY |
1 |
|
BACKGROUND TO INFUSION THERAPY |
1 |
|
FUNCTIONS OF THE CIRCULATORY SYSTEM |
2 |
|
CIRCULATORY SYSTEM |
3 |
|
GENERAL PRINCIPLES IV THERAPY |
3 |
|
TYPES OF IV ADMINISTRATION |
4 |
|
Continuous Intravenous Drip |
4 |
|
Bolus |
4 |
|
Intravenous Push |
4 |
|
Titration |
4 |
|
INFUSION PUMPS |
5 |
|
INFUSION RATE |
5 |
|
INFUSION RATE (CONTINUED) |
6 |
|
FREE FLOW |
7 |
|
START-UP TIME |
8 |
|
GENERAL FEATURES AND SAFEGUARDS |
8 |
|
RISK MANAGEMENT |
9 |
|
SOPHISTICATION OF INFUSION PUMPS |
9 |
|
OCCLUSIONS |
10 |
|
OCCLUSIONS (CONTINUED) |
11 |
|
CHARACTERISTICS, LIMITATIONS, AND CONFIGURATION OF INFUSION DEVICES |
12 |
|
SAFETY ISSUES |
12 |
|
SAFETY ISSUES (CONTINUED) |
13 |
|
SAFETY ISSUES (CONTINUED) |
14 |
|
SAFETY ISSUES (CONTINUED) |
15 |
|
PATIENT COMFORT |
16 |
|
NEW MATERIALS AND SIMPLER DESIGNS |
17 |
|
INSURANCE REIMBURSEMENT ISSUES |
18 |
|
INSURANCE REIMBURSEMENT … (CONTINUED) |
19 |
|
INNOVATIVE TREATMENT OPTIONS |
20 |
|
INFUSION DELIVERY PRESSURE |
21 |
|
HOSPITAL INFUSION |
22 |
|
IMPACT OF HOME INFUSION THERAPY |
23 |
|
Table 1 TYPES OF HOME CARE/ALTERNATE SITE SERVICES |
23 |
|
KEY FACTORS FUELING THE GROWTH IN HOME CARE |
24 |
|
Demographics |
24 |
|
Technology |
25 |
|
Managed Care |
25 |
|
HOME/ALTERNATE SITE INFUSION PROVIDERS |
26 |
|
Regulation |
26 |
|
Provider Trends |
26 |
|
PHARMACEUTICAL SPECIALTY DELIVERY |
27 |
|
GROWTH POTENTIAL |
28 |
|
MEDICARE PART D |
29 |
|
IV THERAPY EDUCATION |
29 |
|
HOME TELEINFUSION |
29 |
|
HOME TELEINFUSION (CONTINUED) |
30 |
|
HOME TELEINFUSION (CONTINUED) |
31 |
|
HOME TELEINFUSION (CONTINUED) |
32 |
|
VERTICAL INTEGRATION ISSUES |
33 |
|
GENERIC PARTICIPATION |
34 |
|
SURGERY AND INFUSION THERAPY |
34 |
|
Table 2 INPATIENT PROCEDURES, 2003 (THOUSANDS) |
34 |
|
Table 2 (CONTINUED) |
35 |
|
Figure 1 INPATIENT PROCEDURES, 2003 (THOUSANDS) |
35 |
|
SKILLED NURSING FACILITIES AND INFUSION THERAPY |
36 |
|
Table 3 SKILLED NURSING FACILITIES, 2002 AND 2003 (THOUSANDS) |
36 |
|
DEMOGRAPHICS |
36 |
|
Table 4 U.S. DEMOGRAPHICS BY SEX AND AGE, 2003-2010 (MILLIONS) |
37 |
|
Figure 2 U.S. DEMOGRAPHICS BY SEX AND AGE, 2003-2010 (MILLIONS) |
37 |
|
DISTRIBUTION OF INTRAVENOUS THERAPY EQUIPMENT |
37 |
|
AMBULATORY INFUSION PUMPS |
38 |
|
PRODUCTS |
39 |
|
6060 Multi-Therapy Infusion Pump |
39 |
|
CADD Infusion Pumps |
39 |
|
Walkmed IC Infusion Pump |
39 |
|
Gemstar Infusion Pump |
39 |
|
Alaris Gemini PC1 Infusion Pump |
40 |
|
2000 Plus Infusion Pump |
40 |
|
Paragon and Vivus 4000 Infusion Pumps |
40 |
|
VIP and Sidekick Infusion Pump |
40 |
|
Ambit Patient Controlled Analgesia (PCA) Infusion Pump |
40 |
|
Eureka-IPTM Infusion Pump |
41 |
|
Delphi Ivantage Infusion Pump |
41 |
|
Automed 3200 |
41 |
|
MARKET AND COMPETITIVE DATA |
42 |
|
Table 5 U.S. MARKET FORECAST FOR AMBULATORY INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
42 |
|
Figure 3 MARKET FORECAST FOR U.S. AMBULATORY INFUSION PUMPS, 2003-2010 ($ MILLIONS) |
43 |
|
Table 6 MANUFACTURERS MARKET SHARE OF AMBULATORY INFUSION PUMPS, 2005 (%) |
43 |
|
Figure 4 MANUFACTURERS MARKET SHARE OF (%) |
44 |
|
CENTRAL VENOUS ACCESS DEVICES |
44 |
|
CENTRAL VENOUS ACCESS …(CONTINUED) |
45 |
|
RISKS |
46 |
|
PRODUCTS |
46 |
|
Arrow Multi-Lumen Access Catheter |
46 |
|
Hickman, Leonard, Broviac And Groshong Catheters |
47 |
|
Cook Catheter |
47 |
|
L-Cath And Mid-Cath |
48 |
|
Tunneled Central Venous Catheters With PASV Valve Technology |
48 |
|
Circle C Chronic And Acute Hemodialysis Catheters |
48 |
|
Lifeport And Infuse-A-Port System |
48 |
|
Vantex Catheter |
49 |
|
MARKET AND COMPETITIVE DATA |
49 |
|
Table 7 U.S. MARKET FORECAST FOR CENTRAL VENOUS ACCESSES, THROUGH 2010 ($ MILLIONS) |
50 |
|
Figure 5 U.S. MARKET FORECAST FOR CENTRAL VENOUS ACCESSES, THROUGH 2010 ($ MILLIONS) |
50 |
|
Table 8 MANUFACTURERS MARKET SHARE OF CENTRAL VENOUS ACCESS, 2005 (%) |
51 |
|
Figure 6 MANUFACTURERS MARKET SHARE OF CENTRAL VENOUS ACCESS, 2005 (%) |
51 |
|
DIABETES INSULIN INFUSION PUMPS |
51 |
|
DIABETES INSULIN INFUSION …(CONTINUED) |
52 |
|
DIABETES INSULIN INFUSION …(CONTINUED) |
53 |
|
PRODUCTS |
54 |
|
Paradigm |
54 |
|
MIP 2001 Promedos ID3 |
54 |
|
Infusaid Model 1000 |
54 |
|
ACCU-CHECK Spirit Insulin Pump |
55 |
|
Animas IR-1250 Insulin Pump |
56 |
|
IR-1000 Insulin Pump |
56 |
|
Cozmore Insulin Technology System |
56 |
|
Omnipod Insulin Management System |
56 |
|
DANA Diabecare II |
57 |
|
Amigo Insulin Pump |
58 |
|
MARKET AND COMPETITIVE DATA |
58 |
|
Table 9 U.S. MARKET FORECAST FOR DIABETES INSULIN INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
59 |
|
Figure 7 MARKET FORECAST FOR U.S. DIABETES INSULIN INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
59 |
|
Table 10 MANUFACTURERS MARKET SHARE OF DIABETES INSULIN INFUSION PUMPS, 2005 (%) |
60 |
|
Figure 8 MANUFACTURERS MARKET SHARE OF DIABETES INSULIN INFUSION PUMPS, 2005 (%) |
60 |
|
ENTERAL FEEDING PUMPS AND TUBES |
60 |
|
PRODUCTS |
61 |
|
Flexiflo, Quantum, and Patrol Enteral Pumps |
61 |
|
Kangaroo Enteral Pumps |
62 |
|
ZEVEX Enteral Pumps |
62 |
|
Compact Enteral Pump |
63 |
|
MARKET AND COMPETITIVE DATA |
64 |
|
Table 11 U.S. MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, THROUGH 2010 ($ MILLIONS) |
64 |
|
Figure 9 U.S. MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, 2003-2010 ($ MILLIONS) |
65 |
|
Table 12 MANUFACTURERS MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2005 (%) |
65 |
|
Figure 10 MANUFACTURERS MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2005 (%) |
66 |
|
IMPLANTABLE INFUSION PUMPS |
66 |
|
ACCESS PORTS |
67 |
|
PULSATIVE PUMPS |
68 |
|
VAPOR-PRESSURE POWERED PUMPS |
68 |
|
PERISTALTIC PUMPS |
69 |
|
PRODUCTS |
70 |
|
Synchromed Infusion System |
70 |
|
MARKET AND COMPETITIVE DATA |
71 |
|
Table 13 U.S. MARKET FORECAST FOR IMPLANTABLE INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
72 |
|
Figure 11 MARKET FORECAST FOR U.S. IMPLANTABLE INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
72 |
|
Table 14 MANUFACTURERS MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2005 (%) |
73 |
|
Figure 12 MANUFACTURERS MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2005 (%) |
73 |
|
Large Volume Infusion Pumps |
73 |
|
Products |
74 |
|
COLLEAGUE Pump |
74 |
|
FLO-GARD 6201 and 6301 |
74 |
|
Hospiar Plum A+ Infusion System |
74 |
|
Omni-Flow 4000 Plus |
75 |
|
Horizon Nxt |
75 |
|
EZ-1 |
75 |
|
Sigma 6000+ |
75 |
|
MARKET AND COMPETITIVE DATA |
75 |
|
Table 15 U.S. MARKET FORECAST FOR LARGE VOLUME INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
76 |
|
Figure 13 MARKET FORECAST FOR U.S. LARGE VOLUME INFUSION PUMPS, 2003- 2010 ($ MILLIONS) |
76 |
|
Table 16 MANUFACTURERS MARKET SHARE OF LARGE VOLUME INFUSION PUMPS, 2005 (%) |
77 |
|
Figure 14 MANUFACTURERS MARKET SHARE OF LARGE VOLUME INFUSION PUMPS, 2005 (%) |
77 |
|
PERIPHERAL VENOUS ACCESS DEVICES |
77 |
|
PRODUCTS |
78 |
|
PASV Valved Venous Access |
78 |
|
V-Cath |
78 |
|
Vygon Lifevac PICC and Nutriline Midline/Midclavicular Catheters |
79 |
|
BD First PICC Catheter and BD First Midcath Midline Catheter |
79 |
|
MARKET AND COMPETITIVE DATA |
79 |
|
Table 17 U.S. MARKET FORECAST FOR PERIPHERAL VENOUS ACCESS DEVICES, THROUGH 2010 ($ MILLIONS) |
80 |
|
Figure 15 MARKET FORECAST FOR U.S. PERIPHERAL VENOUS ACCESS DEVICES, 2003-2010 ($ MILLIONS) |
80 |
|
Table 18 MANUFACTURERS MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2005 (%) |
81 |
|
Figure 16 MANUFACTURERS MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2005 (%) |
81 |
|
SYRINGE INFUSION PUMPS |
81 |
|
PRODUCTS |
82 |
|
Microfuse Syringe Pumps |
82 |
|
AS50A Infusion Pump |
82 |
|
Perfusor Basic |
82 |
|
Excelsior Syringe Pump |
83 |
|
Medi-SIS Syringe Infusion System |
83 |
|
Graseby Syringe Drivers |
83 |
|
Outbound Disposable Syringe Infuser |
83 |
|
Medfusion |
84 |
|
FREEDOM60 Syringe Infusion System |
84 |
|
MARKET AND COMPETITIVE DATA |
84 |
|
Table 19 U.S. MARKET FORECAST OF U.S. SYRINGE INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
85 |
|
Figure 17 MARKET FORECAST OF U.S. SYRINGE INFUSION PUMPS, 2003-2010 ($ MILLIONS) |
86 |
|
Table 20 MANUFACTURERS MARKET SHARE OF SYRINGE INFUSION PUMPS, 2005 (%) |
86 |
|
Figure 18 MANUFACTURERS MARKET SHARE OF SYRINGE INFUSION PUMPS, 2005 (%) |
87 |
|
OTHER |
87 |
|
OTHER (CONTINUED) |
88 |
|
TOTAL MARKET SIZE AND GROWTH |
89 |
|
Table 21 U.S. MARKET FORECAST FOR IV THERAPY DEVICE AND VEIN ACCESS, THROUGH 2010 ($ MILLIONS) |
89 |
|
Figure 19 FORECAST FOR U.S. IV THERAPY DEVICE AND VEIN ACCESS MARKETS, 2003-2010 ($ MILLIONS) |
90 |
|
Figure 20 MARKET SIZE OF U.S. IV THERAPY DEVICE AND VEIN ACCESS MARKETS, 2005 (%) |
90 |
|
Figure 20 (CONTINUED) |
91 |
|
RESEARCH AND DEVELOPMENT |
91 |
|
EKSIGENT |
91 |
|
PDD INNOVATIONS |
91 |
|
NIPRO |
92 |
|
TECHNOLOGY ANALYSIS |
93 |
|
Table 22 U.S. PATENT INFORMATION BY DATE FOR INFUSION/INTRAVENOUS PUMPS AND RELATED |
93 |
|
Table 22 (CONTINUED) |
94 |
|
MARKET ANALYSIS |
95 |
|
MARKET ANALYSIS |
95 |
|
MARKET ANALYSIS (CONTINUED) |
96 |
|
COMPETITIVE ANALYSIS |
97 |
|
Table 23 IV THERAPY DEVICE AND VEIN ACCESS MANUFACTURERS BY TYPE, 2005 |
97 |
|
Table 23 (CONTINUED) |
98 |
|
MARKET OUTLOOK |
99 |
|
MARKET OUTLOOK |
99 |
|
COMPANY PROFILES |
100 |
|
ALARIS MEDICAL SYSTEMS, INC. |
100 |
|
ANIMAS CORPORATION |
100 |
|
ARROW INTERNATIONAL, INC. |
101 |
|
BAXTER INTERNATIONAL, INC. |
101 |
|
BAXTER INTERNATIONAL, INC. (CONTINUED) |
102 |
|
Becton, Dickinson and Company |
103 |
|
Hospira, Inc. |
104 |
|
Kendall Company, The |
105 |
|
Medex, Inc. |
105 |
|
Medtronic, Inc. |
106 |
|
ZEVEX International |
107 |
|
ZEVEX International (Continued) |
108 |
|
APPENDIX |
109 |
|
INFUSION DEVICE DEVELOPERS/MANUFACTURERS |
109 |
|
Table 24 INFUSION DEVICE DEVELOPERS/MANUFACTURERS |
109 |
|
Table 24 (CONTINUED) |
110 |
|
Table 24 (CONTINUED) |
111 |
|
Table 24 (CONTINUED) |
112 |
|
Table 24 (CONTINUED) |
113 |
LIST OF TABLES |
|
|
Summary Table: |
XVIII |
|
Table 1 TYPES OF HOME CARE/ALTERNATE SITE SERVICES |
23 |
|
Table 2 INPATIENT PROCEDURES, 2003 (THOUSANDS) |
34 |
|
Table 3 SKILLED NURSING FACILITIES, 2002 AND 2003 (THOUSANDS) |
36 |
|
Table 4 U.S. DEMOGRAPHICS BY SEX AND AGE, 2003-2010 (MILLIONS) |
37 |
|
Table 5 U.S. MARKET FORECAST FOR AMBULATORY INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
42 |
|
Table 6 MANUFACTURERS MARKET SHARE OF AMBULATORY INFUSION PUMPS, 2005 (%) |
43 |
|
Table 7 U.S. MARKET FORECAST FOR CENTRAL VENOUS ACCESSES, THROUGH 2010 ($ MILLIONS) |
50 |
|
Table 8 MANUFACTURERS MARKET SHARE OF CENTRAL VENOUS ACCESS, 2005 (%) |
51 |
|
Table 9 U.S. MARKET FORECAST FOR DIABETES INSULIN INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
59 |
|
Table 10 MANUFACTURERS MARKET SHARE OF DIABETES INSULIN INFUSION PUMPS, 2005 (%) |
60 |
|
Table 11 U.S. MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, THROUGH 2010 ($ MILLIONS) |
64 |
|
Table 12 MANUFACTURERS MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2005 (%) |
65 |
|
Table 13 U.S. MARKET FORECAST FOR IMPLANTABLE INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
72 |
|
Table 14 MANUFACTURERS MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2005 (%) |
73 |
|
Table 15 U.S. MARKET FORECAST FOR LARGE VOLUME INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
76 |
|
Table 16 MANUFACTURERS MARKET SHARE OF LARGE VOLUME INFUSION PUMPS, 2005 (%) |
77 |
|
Table 17 U.S. MARKET FORECAST FOR PERIPHERAL VENOUS ACCESS DEVICES, THROUGH 2010 ($ MILLIONS) |
80 |
|
Table 18 MANUFACTURERS MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2005 (%) |
81 |
|
Table 19 U.S. MARKET FORECAST OF U.S. SYRINGE INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
85 |
|
Table 20 MANUFACTURERS MARKET SHARE OF SYRINGE INFUSION PUMPS, 2005 (%) |
86 |
|
Table 21 U.S. MARKET FORECAST FOR IV THERAPY DEVICE AND VEIN ACCESS, THROUGH 2010 ($ MILLIONS) |
89 |
|
Table 22 U.S. PATENT INFORMATION BY DATE FOR INFUSION/INTRAVENOUS PUMPS AND RELATED |
93 |
|
Table 23 IV THERAPY DEVICE AND VEIN ACCESS MANUFACTURERS BY TYPE, 2005 |
97 |
|
Table 24 INFUSION DEVICE DEVELOPERS/MANUFACTURERS |
109 |
LIST OF FIGURES |
|
|
Summary Figure: |
XIX |
|
Figure 1 INPATIENT PROCEDURES, 2003 (THOUSANDS) |
35 |
|
Figure 2 U.S. DEMOGRAPHICS BY SEX AND AGE, 2003-2010 (MILLIONS) |
37 |
|
Figure 3 MARKET FORECAST FOR U.S. AMBULATORY INFUSION PUMPS, 2003-2010 ($ MILLIONS) |
43 |
|
Figure 4 MANUFACTURERS MARKET SHARE OF (%) |
44 |
|
Figure 5 U.S. MARKET FORECAST FOR CENTRAL VENOUS ACCESSES, THROUGH 2010 ($ MILLIONS) |
50 |
|
Figure 6 MANUFACTURERS MARKET SHARE OF CENTRAL VENOUS ACCESS, 2005 (%) |
51 |
|
Figure 7 MARKET FORECAST FOR U.S. DIABETES INSULIN INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
59 |
|
Figure 8 MANUFACTURERS MARKET SHARE OF DIABETES INSULIN INFUSION PUMPS, 2005 (%) |
60 |
|
Figure 9 U.S. MARKET FORECAST FOR ENTERAL FEEDING PUMPS AND TUBES, 2003-2010 ($ MILLIONS) |
65 |
|
Figure 10 MANUFACTURERS MARKET SHARE OF ENTERAL FEEDING PUMPS AND TUBES, 2005 (%) |
66 |
|
Figure 11 MARKET FORECAST FOR U.S. IMPLANTABLE INFUSION PUMPS, THROUGH 2010 ($ MILLIONS) |
72 |
|
Figure 12 MANUFACTURERS MARKET SHARE OF IMPLANTABLE INFUSION PUMPS, 2005 (%) |
73 |
|
Figure 13 MARKET FORECAST FOR U.S. LARGE VOLUME INFUSION PUMPS, 2003- 2010 ($ MILLIONS) |
76 |
|
Figure 14 MANUFACTURERS MARKET SHARE OF LARGE VOLUME INFUSION PUMPS, 2005 (%) |
77 |
|
Figure 15 MARKET FORECAST FOR U.S. PERIPHERAL VENOUS ACCESS DEVICES, 2003-2010 ($ MILLIONS) |
80 |
|
Figure 16 MANUFACTURERS MARKET SHARE OF PERIPHERAL VENOUS ACCESS DEVICES, 2005 (%) |
81 |
|
Figure 17 MARKET FORECAST OF U.S. SYRINGE INFUSION PUMPS, 2003-2010 ($ MILLIONS) |
86 |
|
Figure 18 MANUFACTURERS MARKET SHARE OF SYRINGE INFUSION PUMPS, 2005 (%) |
87 |
|
Figure 19 FORECAST FOR U.S. IV THERAPY DEVICE AND VEIN ACCESS MARKETS, 2003-2010 ($ MILLIONS) |
90 |
|
Figure 20 MARKET SIZE OF U.S. IV THERAPY DEVICE AND VEIN ACCESS MARKETS, 2005 (%) |
90 |
CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: jenniferc@cmsinfo.com
copyright © 2005 all rights reserved
For more information about us, visit CMSinfo.
